Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pathological Angiogenesis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00504959
What this trial is testing

Safety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Who this might be right for
Subfoveal Choroidal Neovascularization (CNV)Secondary to Age-related Macular Degeneration (AMD)
Novartis 234
Early research (Phase 1)Study completedNCT00681889
What this trial is testing

Effectiveness and Safety of Topical Ranibizumab for Treatment of Corneal Neovascularization (NV)

Who this might be right for
Corneal Neovascularization
Reza Dana, MD 9
Not applicableUnknownNCT04707027
What this trial is testing

Interval of Disease Inactivity After Complete Polypoidal Regression in PCV Receiving Aflibercept

Who this might be right for
Polypoidal Choroidal Vasculopathy
Chiang Mai University 80
Not applicableStudy completedNCT03964623
What this trial is testing

Impact of Nicotine on Retinal Vascularization

Who this might be right for
Tabagism
Fondation Ophtalmologique Adolphe de Rothschild 58
Not applicableUnknownNCT02259257
What this trial is testing

3D/4D Ultrasound Contrast Enhanced Imaging (CEUS) for Carotid Plaque Vulnerability

Who this might be right for
AtherosclerosisStroke
Diana Gaitini MD. 50
Post-approval studies (Phase 4)UnknownNCT01657669
What this trial is testing

Short-term Clinical Effects of Intravitreal Aflibercept Injection 2.0mg as a Predictor of Long-term Results

Who this might be right for
Age Related Macular Degeneration
Retina Research Institute, LLC 22
Post-approval studies (Phase 4)Study completedNCT05269966
What this trial is testing

Study to Evaluate the Safety and Effectiveness of Intravitreal Injections (IVI) of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Novartis Pharmaceuticals 105
Testing effectiveness (Phase 2)Ended earlyNCT01778530
What this trial is testing

TRC105 for Recurrent Glioblastoma

Who this might be right for
Glioblastoma Multiforme
National Cancer Institute (NCI) 2
Not applicableStudy completedNCT00379795
What this trial is testing

An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVO

Who this might be right for
Choroidal Neovascularization, Age-related Macular Degeneration
Genentech, Inc. 853
Testing effectiveness (Phase 2)Study completedNCT01023295
What this trial is testing

Study Evaluating the Safety and Response of Fosbretabulin in Asian Patients With Polypoidal Choroidal Vasculopathy (PCV)

Who this might be right for
Polypoidal Choroidal Vasculopathy
Mateon Therapeutics 20
Not applicableEnded earlyNCT01229540
What this trial is testing

Clinical Research on Retinal Neovascularization of Diabetic Retinopathy

Who this might be right for
The Mechanism of Retinal Neovascularization of DiabeticRetinopathy.
Tianjin Medical University
Not applicableWithdrawnNCT03435926
What this trial is testing

OCT and Microperimetry in Patients With Active Neovascular ARMD (CORFI)

Who this might be right for
Choroidal Neovascularization, Visual Field, Visual Acuity
University Hospital, Limoges
Post-approval studies (Phase 4)Study completedNCT04881110
What this trial is testing

Liraglutide and Peripheral Artery Disease

Who this might be right for
Type 2 DiabetesPeripheral Arterial Disease
University of Campania Luigi Vanvitelli 60
Large-scale testing (Phase 3)Ended earlyNCT03111238
What this trial is testing

The Efficacy and Safety of REX-001 to Treat Ischemic Rest Pain in Subjects With CLI Rutherford Category 4 and DM

Who this might be right for
Peripheral Arterial Disease (PAD)Diabetes Mellitus (DM)Diabetes Mellitus, Type 1+3 more
Ixaka Ltd 3
Not applicableActive Not RecruitingNCT06527274
What this trial is testing

Effect of Defocus in Soft Contact Lenses on Internal Retinal Vascularization

Who this might be right for
Nearsightedness
Université de Montréal 25
Not applicableStudy completedNCT02759796
What this trial is testing

Fluorescence Angiography in the Assessment of DIEP Flap Perfusion

Who this might be right for
Breast CancerVascularizationFat Necrosis
Instituto de Investigación Hospital Universitario La Paz 60
Testing effectiveness (Phase 2)Study completedNCT01494805
What this trial is testing

Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration

Who this might be right for
Macular DegenerationAge-related MaculopathiesAge-related Maculopathy+5 more
Lions Eye Institute, Perth, Western Australia 40
Not applicableStudy completedNCT01832519
What this trial is testing

Using MRI to Observe Lung Changes in Infants With CF Compared to Infants Without CF

Who this might be right for
Cystic Fibrosis
Children's Hospital Medical Center, Cincinnati 20
Not applicableStudy completedNCT00001733
What this trial is testing

Screening for Studies on Retinovascular Diseases

Who this might be right for
Diabetic RetinopathyMacular DegenerationPathologic Neovascularization+1 more
National Eye Institute (NEI) 2,000
Not applicableStudy completedNCT00692887
What this trial is testing

Correlation Between Visual Field Defects on Foresee Preferential Hyperacuity Perimeter(PHP) and on Optical Coherence Tomography (OCT) in Patients With Choroidal Neovascularization (CNV)

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 15
Next Page